Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18318429rdf:typepubmed:Citationlld:pubmed
pubmed-article:18318429lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0023449lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0003993lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0042679lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0146224lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:18318429lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:18318429pubmed:issue9lld:pubmed
pubmed-article:18318429pubmed:dateCreated2008-4-28lld:pubmed
pubmed-article:18318429pubmed:abstractTextThe authors evaluated the response rate, toxicity, and pharmacokinetics of topotecan given before standard induction therapy for childhood acute lymphoblastic leukemia (ALL) in first relapse.lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:languageenglld:pubmed
pubmed-article:18318429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18318429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18318429pubmed:statusMEDLINElld:pubmed
pubmed-article:18318429pubmed:monthMaylld:pubmed
pubmed-article:18318429pubmed:issn0008-543Xlld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:PuiChing-HonC...lld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:RellingMary...lld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:GajjarAmarAlld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:StewartClinto...lld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:Coustan-Smith...lld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:CampanaDarioDlld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:RiveraGaston...lld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:ZhouYinmeiYlld:pubmed
pubmed-article:18318429pubmed:authorpubmed-author:HijiyaNobukoNlld:pubmed
pubmed-article:18318429pubmed:issnTypePrintlld:pubmed
pubmed-article:18318429pubmed:day1lld:pubmed
pubmed-article:18318429pubmed:volume112lld:pubmed
pubmed-article:18318429pubmed:ownerNLMlld:pubmed
pubmed-article:18318429pubmed:authorsCompleteYlld:pubmed
pubmed-article:18318429pubmed:pagination1983-91lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:meshHeadingpubmed-meshheading:18318429...lld:pubmed
pubmed-article:18318429pubmed:year2008lld:pubmed
pubmed-article:18318429pubmed:articleTitlePhase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.lld:pubmed
pubmed-article:18318429pubmed:affiliationDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA. nhijiya@childrensmemorial.orglld:pubmed
pubmed-article:18318429pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18318429pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18318429pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:18318429pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18318429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18318429lld:pubmed